Viral Hepatitis B+D: Modern Course

Authors

  • Vafakulov S. H. Doctor of Medical Sciences, Professor, Samarkand State Medical University, Department of Infectious Diseases
  • Jumanazarov Sardorbek Samarkand State Medical University, 2nd-year Residents of the Department of Infectious Diseases
  • Khidirov Akbar Samarkand State Medical University, 2nd-year Residents of the Department of Infectious Diseases
  • Bekmirzaev Sanjar Samarkand State Medical University, 2nd-year Residents of the Department of Infectious Diseases
  • Kuziyeva Dilobar Samarkand State Medical University, 2nd-year Residents of the Department of Infectious Diseases

Keywords:

Hepatitis B, Hepatitis D, Coinfection, Antiviral therapy

Abstract

Hepatitis B (HBV) and Hepatitis D (HDV) coinfection significantly worsens liver disease outcomes, leading to higher risks of cirrhosis and liver cancer. This article reviews the modern understanding of HBV+HDV coinfection, covering its pathogenesis, diagnosis, and treatment. Current therapies, including interferon and emerging antivirals like bulevirtide, are discussed, along with the importance of HBV vaccination for prevention. The need for more effective treatments and global public health efforts to reduce coinfection rates is emphasized.

Downloads

Published

2024-10-26

How to Cite

S. H., V., Sardorbek, J., Akbar, K., Sanjar, B., & Dilobar, K. (2024). Viral Hepatitis B+D: Modern Course. Miasto Przyszłości, 53, 1275–1277. Retrieved from http://miastoprzyszlosci.com.pl/index.php/mp/article/view/5058

Issue

Vol. 53 (2024): Miasto Przyszłości

Section

Articles